{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:16:06Z","timestamp":1793344566787,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"am","delay-in-days":267,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA007583"],"award-info":[{"award-number":["AA007583"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA048336"],"award-info":[{"award-number":["DA048336"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110467","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:55:50Z","timestamp":1744725350000},"page":"110467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Behavioral economics of polysubstance use: The role of orexin-1 receptors in nicotine-induced augmentation of synthetic opioid consumption"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0106-3236","authenticated-orcid":false,"given":"Sarah C.","family":"Honeycutt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Gilles-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Lichte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"McSain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashmita","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-1885","authenticated-orcid":false,"given":"Gregory C.","family":"Loney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110467_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110467_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002130051121","article-title":"Long-lasting increase in the set point for cocaine self-administration after escalation in rats","volume":"146","author":"Ahmed","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.106","article-title":"Lateral hypothalamic orexin\/hypocretin neurons: a role in reward-seeking and addiction","volume":"1314","author":"Aston-Jones","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bph.12639","article-title":"Orexin\/hypocretin role in reward: implications for opioid and other addictions","volume":"172","author":"Baimel","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ejn.12866","article-title":"Orexin\u20101 receptor signaling increases motivation for cocaine\u2010associated cues","volume":"41","author":"Bentzley","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00213-012-2899-2","article-title":"The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures","volume":"226","author":"Bentzley","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/adb.12553","article-title":"Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine","volume":"23","author":"Bernstein","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neubiorev.2010.02.006","article-title":"Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system","volume":"35","author":"Berrendero","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110467_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FBP.0000000000000593","article-title":"Early adolescent subchronic low-dose nicotine exposure increases subsequent cocaine and fentanyl self-administration in Sprague-Dawley rats","volume":"32","author":"Cardenas","year":"2021","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib10","doi-asserted-by":"crossref","first-page":"E9125","DOI":"10.1073\/pnas.1705753114","article-title":"Opioid and orexin hedonic hotspots in rat orbitofrontal cortex and insula","volume":"114","author":"Castro","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106716","article-title":"Nicotine on the developing brain","volume":"190","author":"Castro","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1037\/0278-6133.15.6.478","article-title":"The natural history of cigarette smoking from adolescence to adulthood: demographic predictors of continuity and change","volume":"15","author":"Chassin","year":"1996","journal-title":"Health Psychol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.neuropharm.2025.110467_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(96)01331-2","article-title":"Smoking habits and attitudes in a methadone maintenance treatment population","volume":"44","author":"Clemmey","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110467_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcpp.12516","article-title":"Annual Research Review: on the developmental neuropsychology of substance use disorders","volume":"57","author":"Conrod","year":"2016","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"key":"10.1016\/j.neuropharm.2025.110467_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-009-1588-2","article-title":"Hypocretin mechanisms in nicotine addiction: evidence and speculation","volume":"206","author":"Corrigall","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1345\/aph.1D580","article-title":"Postoperative opiate analgesia requirements of smokers and nonsmokers","volume":"38","author":"Creekmore","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110467_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2021.12.030","article-title":"Nicotine and opioid co-dependence: findings from bench research to clinical trials","volume":"134","author":"Custodio","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110467_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2009.02.003","article-title":"The dynamic effects of nicotine on the developing brain","volume":"122","author":"Dwyer","year":"2009","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.neuropharm.2025.110467_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-394623-2.00010-X","article-title":"Hypocretin\/orexin involvement in reward and reinforcement","volume":"89","author":"Espa\u00f1a","year":"2012","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.neuropharm.2025.110467_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin\u2013orexin system regulates cocaine self\u2010administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100026","article-title":"Ventral pallidum GABA neurons bidirectionally control opioid relapse across rat behavioral models","volume":"3","author":"Farrell","year":"2022","journal-title":"Addiction Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110467_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2011.01.040","article-title":"Blocking \u03b14\u03b22 and \u03b17 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice","volume":"220","author":"Feng","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib25","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41386-019-0420-x","article-title":"The role of orexin-1 receptor signaling in demand for the opioid fentanyl","volume":"44","author":"Fragale","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12946","article-title":"Intermittent self\u2010administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system","volume":"26","author":"Fragale","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajim.20191","article-title":"Opioid dosing trends and mortality in Washington State workers' compensation, 1996\u20132002","volume":"48","author":"Franklin","year":"2005","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.neuropharm.2025.110467_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108602","article-title":"The phenomics and genetics of addictive and affective comorbidity in opioid use disorder","volume":"221","author":"Freda","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1096213","article-title":"Impact of tobacco smoke constituents on nicotine-seeking behavior in adolescent and adult male rats","volume":"14","author":"Gellner","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110467_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2006.03.045","article-title":"18-Methoxycoronaridine acts in the medial habenula and\/or interpeduncular nucleus to decrease morphine self-administration in rats","volume":"537","author":"Glick","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ntr\/ntr048","article-title":"Smoking prevalence in addiction treatment: a review","volume":"13","author":"Guydish","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10550490701756112","article-title":"Cigarette smoking in opioid-using patients presenting for hospital-based medical services","volume":"17","author":"Haas","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2025.110467_bib33","doi-asserted-by":"crossref","first-page":"19480","DOI":"10.1073\/pnas.0808023105","article-title":"Insular hypocretin transmission regulates nicotine reward","volume":"105","author":"Hollander","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13170","article-title":"Acute nicotine treatment enhances compulsive-like remifentanil self-administration that persists despite contextual punishment","volume":"27","author":"Honeycutt","year":"2022","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100150","article-title":"Adolescent nicotine exposure promotes adulthood opioid consumption that persists despite adverse consequences and increases the density of insular perineuronal nets","author":"Honeycutt","year":"2024","journal-title":"Addiction Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110467_bib36","first-page":"1","article-title":"Acute nicotine administration reduces the efficacy of punishment in curbing remifentanil consumption in a seeking-taking chain schedule of reinforcement","author":"Honeycutt","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2105\/AJPH.2004.057232","article-title":"Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States","volume":"96","author":"Hu","year":"2006","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.neuropharm.2025.110467_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1901\/jeab.1980.34-219","article-title":"Economic concepts for the analysis of behavior","volume":"34","author":"Hursh","year":"1980","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2025.110467_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110467_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1127735","article-title":"Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats","volume":"14","author":"Illenberger","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib41","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1111\/ejn.14166","article-title":"Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin\/hypocretin\u20101 receptor antagonist in rats","volume":"50","author":"James","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10550490590924728","article-title":"Co-morbidity of smoking in patients with psychiatric and substance use disorders","volume":"14","author":"Kalman","year":"2005","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2025.110467_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2007.04.011","article-title":"On the development of nicotine dependence in adolescence","volume":"91","author":"Kandel","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib44","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/endo.141.10.7707","article-title":"Nicotine up-regulates expression of orexin and its receptors in rat brain","volume":"141","author":"Kane","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2012.12030321","article-title":"Early smoking onset and risk for subsequent nicotine dependence: a monozygotic co-twin control study","volume":"170","author":"Kendler","year":"2013","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110467_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.pbb.2010.08.015","article-title":"Tobacco dependence, the insular cortex and the hypocretin connection","volume":"97","author":"Kenny","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110467_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/1064-1297.9.3.251","article-title":"Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats","volume":"9","author":"Klein","year":"2001","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110467_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00952990.2016.1209513","article-title":"Interactions between nicotine and drugs of abuse: a review of preclinical findings","volume":"43","author":"Kohut","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2025.110467_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2014.00016","article-title":"Hypocretin (orexin) regulation of sleep-to-wake transitions","volume":"5","author":"Lecea","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-010-1792-0","article-title":"Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA","volume":"209","author":"LeSage","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jnc.14568","article-title":"Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats","volume":"147","author":"Liu","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110467_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugalcdep.2018.07.048","article-title":"Nicotine pre-treatment reduces sensitivity to the interoceptive stimulus effects of commonly abused drugs as assessed with taste conditioning paradigms","volume":"194","author":"Loney","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib53","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/acer.14043","article-title":"Nicotine produces a high\u2010approach, low\u2010avoidance phenotype in response to alcohol\u2010associated cues in male rats","volume":"43","author":"Loney","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib54","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1038\/s41598-021-81955-5","article-title":"Systemic nicotine enhances opioid self-administration and modulates the formation of opioid-associated memories partly through actions within the insular cortex","volume":"11","author":"Loney","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110467_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drugalcdep.2007.01.002","article-title":"A behavioral economic measure of demand for alcohol predicts brief intervention outcomes","volume":"89","author":"MacKillop","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib56","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106752","article-title":"High prevalence of co-occurring substance use in individuals with opioid use disorder","volume":"114","author":"Mahoney","year":"2021","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110467_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107906","article-title":"Targeting the orexin system for prescription opioid use disorder: orexin-1 receptor blockade prevents oxycodone taking and seeking in rats","volume":"164","author":"Matzeu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110467_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ntt.2006.10.012","article-title":"Low dose nicotine treatment during early adolescence increases subsequent cocaine reward","volume":"29","author":"McQuown","year":"2007","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100036","article-title":"Habitual behaviour associated with exposure to high-calorie diet is prevented by an orexin-receptor-1 antagonist","volume":"4","author":"Merlin","year":"2022","journal-title":"Addiction Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110467_bib61","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1523\/JNEUROSCI.0255-19.2019","article-title":"Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil","volume":"39","author":"Mohammadkhani","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146461","article-title":"Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil","volume":"1731","author":"Mohammadkhani","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.drugalcdep.2013.04.003","article-title":"Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats","volume":"132","author":"Morgan","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110467_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11414-020-09712-6","article-title":"Nicotine and opioids: a call for Co-treatment as the standard of Care","volume":"47","author":"Morris","year":"2020","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib65","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.addbeh.2006.01.006","article-title":"Cigarette smoking and interest in quitting in methadone maintenance patients","volume":"31","author":"Nahvi","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110467_bib66","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/bdr2.1182","article-title":"Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders","volume":"109","author":"Nock","year":"2017","journal-title":"Birth defects research"},{"key":"10.1016\/j.neuropharm.2025.110467_bib67","article-title":"The dual orexin\/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl","volume":"2020","author":"O'Connor","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110467_bib68","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ntr\/ntaa189","article-title":"Opioid use disorder trends from 2002 to 2017 by cigarette smoking status in the United States","volume":"23","author":"Parker","year":"2021","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib69","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","article-title":"Vertical shifts in self-administration dose\u2013response functions predict a drug-vulnerable phenotype predisposed to addiction","volume":"20","author":"Piazza","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib70","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12035-012-8255-z","article-title":"The hypocretin\/orexin system: implications for drug reward and relapse","volume":"45","author":"Plaza-Zabala","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/adb.12323","article-title":"Individual differences in orexin\u2010I receptor modulation of motivation for the opioid remifentanil","volume":"22","author":"Porter\u2010Stransky","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/187152706777452218","article-title":"Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis","volume":"5","author":"Sakurai","year":"2006","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2025.110467_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/tobaccocontrol-2018-054593","article-title":"Age of tobacco use initiation and association with current use and nicotine dependence among US middle and high school students, 2014\u20132016","volume":"29","author":"Sharapova","year":"2020","journal-title":"Tob. Control"},{"key":"10.1016\/j.neuropharm.2025.110467_bib75","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.annepidem.2010.03.010","article-title":"Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study","volume":"20","author":"Skurtveit","year":"2010","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1460-9568.2012.08013.x","article-title":"Orexin\/hypocretin 1 receptor antagonist reduces heroin self\u2010administration and cue\u2010induced heroin seeking","volume":"35","author":"Smith","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110467_bib77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","article-title":"Routes of drug use among drug overdose deaths - United States, 2020-2022","volume":"73","author":"Tanz","year":"2024","journal-title":"Mmwr-Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.neuropharm.2025.110467_bib78","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110467_bib79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/15360288.2015.1063559","article-title":"Opioid analgesics and nicotine: more than blowing smoke","volume":"29","author":"Yoon","year":"2015","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110467_bib80","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1113\/JP270492","article-title":"Nicotine and the adolescent brain","volume":"593","author":"Yuan","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110467_bib81","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/ntr\/ntu227","article-title":"Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: results from a nationally representative sample","volume":"17","author":"Zale","year":"2014","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2025.110467_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(02)01002-X","article-title":"Cross-tolerance between morphine-and nicotine-induced conditioned place preference in mice","volume":"74","author":"Zarrindast","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110467_bib83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1874473711306010009","article-title":"Cigarette smoking in methadone maintained patients: an up-to-date review","volume":"6","author":"Zirakzadeh","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2025.110467_bib84","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-007-0724-0","article-title":"A critical transition in cocaine self-administration: behavioral and neurobiological implications","volume":"192","author":"Zittel-Lazarini","year":"2007","journal-title":"Psychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:57:40Z","timestamp":1762214260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082500173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":84,"alternative-id":["S002839082500173X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110467","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral economics of polysubstance use: The role of orexin-1 receptors in nicotine-induced augmentation of synthetic opioid consumption","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110467"}}